|
April 18 2007
Speaker Presentations available (Username & Password required)
April 12 2007
Breakthrough Alliance Winner: Takeda/Affymax
April 2 2007
Speaker Bios added:
Pablo Legorreta, Chief Executive Officer, Royalty Pharma
Tom Crawford Perkins, Senior Vice President, NovaQuest
Bryan Roberts, Ph.D., Managing General Partner, Venrock Associates
Neil J. Sandler, Managing Director, Symphony Capital
Eckard Weber, M.D., Partner, Domain Associates
March 30 2007
Speaker Bio added:
Adelene Q. Perkins, EVP & Chief Business Officer, Infinity Pharmaceuticals
March 28 2007
Speakers added:
Adelene Perkins, EVP & Chief Business Officer, Infinity Pharmaceuticals
Tom Perkins, Senior VP Corporate Development, NovaQuest
March 20 2007
Speaker Bios added:
Warwick S. Bedwell, Vice President, Global Head of Business Development, Roche Pharma Partnering
David Schnell, M.D., Managing Director, Prospect Venture Partners
March 8 2007
Speaker Bio added:
K. Peter Hirth, Ph.D., Chief Executive Officer, Plexxikon
Barry A. Labinger, Executive Vice President and Chief Commercial Officer, Human Genome Sciences
March 5 2007
Speaker Bio added:
Ad Rawcliffe, SVP, Worldwide Business Development, GlaxoSmithKline
March 5 2007
Speaker added:
Warwick S. Bedwell, Global Head of Business Development, Roche Pharma Partnering
Speaker Bio added:
Michael Ross, Ph.D., Managing Partner, SV Life Sciences
February 27 2007
Speaker Bio added:
Edmund P. Harrigan, M.D., Senior Vice President, Worldwide Business Development, Pfizer
February 24 2007
Speaker Bio added:
Maria C. Freire, Ph.D., President & CEO, Global Alliance for TB Drug Development
February 22 2007
Speaker Bios added:
Charles Homcy, M.D., Chief Executive Officer, Portola Pharmaceuticals
Dr. Cynthia Robbins-Roth, Founding Partner, BioVenture Consultants
Stephen A Sherwin, M.D., Chairman & CEO, Cell Genesys
February 20 2007
Agenda available
Speakers added:
Maria C. Freire, Ph.D., President & CEO, Global Alliance for TB Drug Development
Charles Homcy, M.D., Chief Executive Officer, Portola Pharmaceuticals
Dr. Cynthia Robbins-Roth, Founding Partner, BioVenture Consultants
Stephen A Sherwin, M.D., Chairman & CEO, Cell Genesys
Speaker Bio added:
Kenneth E. Weg, Chairman, Clearview Projects
February 15 2007
Speaker Bios added:
Deborah Dunsire, MD, Chief Executive Officer, Millennium Pharmaceuticals
Thomas Hofstaetter, Ph.D., Senior Vice President, Corporate Business Development, Wyeth
Dr. Thomas A. Picone, Vice President, Strategic Alliances, Schering-Plough
February 14 2007
Speakers added:
Graham Brazier, Vice President & Head of Business Development, Bristol-Myers Squibb
Pablo Legorreta, Chief Executive Officer, Royalty Pharma
Neil J. Sandler, Managing Director, Symphony Capital
Speaker Bios added:
Dr. Graham Brazier, Vice President, Business Development, Bristol-Myers Squibb
Maxine Gowen, Ph.D., Senior Vice President, External Drug Discovery, GlaxoSmithKline
February 13 2007 Speaker Bio added:
Barbara Yanni, Vice President & Chief Licensing Officer, Merck & Co.
February 12 2007
Speaker added:
Michael Ross, Ph.D., Managing Partner, SV Life Sciences
Speaker Bios added:
Brian G. Atwood, Managing Director, Versant Ventures
Mark Edwards, Managing Director, Recombinant Capital
Scott Foraker, Vice President, Licensing, Amgen
Michael G. McCully, Director and Senior Analyst, Recombinant Capital
Arlene M. Morris, President and CEO, Affymax
Chen Schor, Chief Business Officer, EPIX Pharmaceuticals
Sally Stephens, Vice President, Business Development & Strategic Planning, Novartis, Vaccines & Diagnostics
Mark C. Wiggins, Executive Vice President, Corporate & Business Development, Biogen Idec
February 7 2007
Speakers added:
David Schnell, M.D., Managing Director, Prospect Venture Partners
Sally Stephens, Vice President, Business Development & Strategic Planning, Novartis
Mark C. Wiggins, Executive Vice President, Business Development, Biogen Idec
February 1 2007
Speakers added:
Bryan Roberts Ph.D. , Managing General Partner, Venrock Associates
Eckard Weber, Partner, Domain Associates
January 29 2007 Speaker added:
John Goddard, Senior Vice President, Head of Strategic Planning and Business Development, AstraZeneca
January 23 2007 Speakers added:
Brian G. Atwood, Managing Director, Versant Ventures
Ad Rawcliffe, SVP, Worldwide Business Development, GlaxoSmithKline
January 17 2007 Speakers' list available
November 1 2006 Early Registration available
|
|
|